Our process is transparent and reproducible, making biological interpretation possible.
We apply our proprietary, domain-specific Artificial Intelligence (AI) algorithms to reveal novel patterns and casual dependencies to advance biological understanding.
Our approach uncovers new and actionable insights from the exponentially growing pool of genomic and phenotypic data in precision medicine. Our capabilities speed genomic research as well as drug discovery, design, and development, including optimal clinical trial design.
We provide leading-edge data analysis to:
Tom Chittenden, head of WuXi NextCODE’s AI team, was recently named one of the “Top 100 AI Leaders in Drug Discovery and Advanced Healthcare.” Analysts at Deep Knowledge Analytics drew up the list from a pool of several hundred renowned scientists.Learn More
We're proud to announce a new partnership with Rhythm Pharmaceuticals that will accelerate drug discovery for rare genetic obesity disorders.Learn More
Boston Children’s Hospital and Harvard Medical School-led study in Science leverages WuXi NextCODE's expertise in feature selection and pathway enrichment. Study shows how individual neurons accumulate mutations over time and how this process differs between normally aging people and those with early-onset disease.Learn More